Oral prednisolone versus non-steroidal anti-inflammatory drugs in the treatment of acute gout: a meta-analysis of randomized controlled trials
暂无分享,去创建一个
Zhijun Xie | Chengping Wen | Jia Zhou | Jie Yu | Haimei Lu | Zhenghao Xu
[1] M. Ruospo,et al. Corticosteroid or Nonsteroidal Antiinflammatory Drugs for the Treatment of Acute Gout: A Systematic Review of Randomized Controlled Trials , 2018, The Journal of Rheumatology.
[2] Youde Yan,et al. Benefit-risk of corticosteroids in acute gout patients: An updated meta-analysis and economic evaluation , 2017, Steroids.
[3] C. Nunes,et al. Nonsteroidal Anti‐Inflammatory Therapy: A Journey Toward Safety , 2017, Medicinal research reviews.
[4] Chengping Wen,et al. Treatment of rheumatoid arthritis with combination of methotrexate and Tripterygium wilfordii: A meta‐analysis , 2017, Life sciences.
[5] M. Doherty,et al. Gout - a guide for the general and acute physicians. , 2017, Clinical medicine.
[6] P. Shekelle,et al. Management of Gout: A Systematic Review in Support of an American College of Physicians Clinical Practice Guideline , 2017 .
[7] A. Qaseem,et al. Management of Acute and Recurrent Gout: A Clinical Practice Guideline From the American College of Physicians. , 2017, Annals of internal medicine.
[8] Kathryn Majors-Foley. Oral Prednisolone in the Treatment of Acute Gout: A Pragmatic, Multicenter, Double-Blind, Randomized Trial , 2016 .
[9] Meiping Guan,et al. Comparison of Prednisolone, Etoricoxib, and Indomethacin in Treatment of Acute Gouty Arthritis: An Open-Label, Randomized, Controlled Trial , 2016, Medical science monitor : international medical journal of experimental and clinical research.
[10] T. Rainer,et al. Oral Prednisolone in the Treatment of Acute Gout: A Pragmatic, Multicenter, Double-Blind, Randomized Trial. , 2016, Annals of internal medicine.
[11] Zhong Chen,et al. The efficacy and safety of rufinamide in drug-resistant epilepsy: A meta-analysis of double-blind, randomized, placebo controlled trials , 2016, Epilepsy Research.
[12] R. Nixon,et al. Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis , 2015, Arthritis Research & Therapy.
[13] C. Bombardier,et al. The efficacy and safety of treatments for acute gout: results from a series of systematic literature reviews including Cochrane reviews on intraarticular glucocorticoids, colchicine, nonsteroidal antiinflammatory drugs, and interleukin-1 inhibitors. , 2014, The Journal of rheumatology. Supplement.
[14] F. Becce,et al. 2016 updated EULAR evidence-based recommendations for the management of gout , 2014, Annals of the rheumatic diseases.
[15] P. McGettigan,et al. Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies , 2011, PLoS medicine.
[16] T. Rainer,et al. Oral prednisolone is more cost-effective than oral indomethacin for treating patients with acute gout-like arthritis , 2009, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.
[17] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.
[18] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.
[19] C. Weel,et al. Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial , 2008, The Lancet.
[20] P. Lucassen,et al. Systemic corticosteroids for acute gout. , 2008, The Cochrane database of systematic reviews.
[21] P. Cameron,et al. Comparison of Oral Prednisolone/Paracetamol and Oral Indomethacin/Paracetamol Combination Therapy in the Treatment of Acute Goutlike Arthritis: A Double-Blind, Randomized, Controlled Trial , 2007, Annals of Emergency Medicine.
[22] Joseph Beyene,et al. Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data , 2007, BMC medical research methodology.
[23] Frieder Keller,et al. Pharmacokinetics and Pharmacodynamics of Systemically Administered Glucocorticoids , 2005, Clinical Pharmacokinetics.
[24] M. Oremus,et al. Interrater Reliability of the Modified Jadad Quality Scale for Systematic Reviews of Alzheimer’s Disease Drug Trials , 2001, Dementia and Geriatric Cognitive Disorders.
[25] M. Janssen,et al. Systemic corticosteroids for acute gout (Review) , 2008 .